Literature DB >> 16892094

Systemic management of bladder cancer in Egypt: revisited.

Hussein M Khaled1.   

Abstract

Bladder cancer is still the most frequent malignant tumor among Egyptian males. It has a peculiar biologic, clinico-pathologic features and responsiveness to chemotherapy profile than that observed in Western countries. The current review aims to demonstrate the present state-of- art in using systemic therapy as part of the management options available to treat such patients at different stages of their disease. Individualizing therapy for these patients based on more rationale basis is the challenge that oncologists must face in the near future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16892094

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  9 in total

1.  Expression of O-Alkylguanine-DNA Alkyltransferase in Normal and Malignant Bladder Tissue of Egyptian Patients.

Authors:  Abir A Saad; Heba Sh Kassem; Andrew C Povey; Geoffrey P Margison
Journal:  J Nucleic Acids       Date:  2010-10-17

2.  Chemical neurolysis of the inferior hypogastric plexus for the treatment of cancer-related pelvic and perineal pain.

Authors:  Sahar Abd-Elbaky Mohamed; Doaa Gomaa Ahmed; Mohamad Farouk Mohamad
Journal:  Pain Res Manag       Date:  2013-05-28       Impact factor: 3.037

3.  Incidence analyses of bladder cancer in the Nile delta region of Egypt.

Authors:  Stacey A Fedewa; Amr S Soliman; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Hoda G Omar; Jerome Nriagu; Mark L Wilson
Journal:  Cancer Epidemiol       Date:  2009-09-16       Impact factor: 2.984

4.  Genetic aberrations of the K-ras proto-oncogene in bladder cancer in relation to pesticide exposure.

Authors:  Diaa A Hameed; Heba A Yassa; Michael N Agban; Randa T Hanna; Ahmed M Elderwy; Mohamed A Zwaita
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-12       Impact factor: 4.223

5.  Detubularised isolated ureterosigmoidostomy (Atta pouch): Manometric and radiological studies in a sample of patients.

Authors:  Mohamed A Atta; Tamer A Youssif; Tamer A Youssef; Gerges F Boules; Ahmed F Kotb
Journal:  Arab J Urol       Date:  2014-03-24

6.  Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.

Authors:  Kamel Z Hemmaid; Amira Awadalla; Essam Elsawy; Abdel-Aziz M Hussein; Azza Abdel-Aziz; Ahmed A Shokeir; Ahmed S El-Hefnawy; Hassan Abol-Enein
Journal:  Infect Agent Cancer       Date:  2013-06-28       Impact factor: 2.965

Review 7.  Schistosomiasis and cancer in egypt: review.

Authors:  Hussein Khaled
Journal:  J Adv Res       Date:  2013-06-26       Impact factor: 10.479

8.  Prognostic Role of Epithelial-Mesenchymal Transition Markers "E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63" in Bladder Carcinoma.

Authors:  Rabab Ahmed Moussa; El Zahraa Ibrahim Khalil; Ahmed Issam Ali
Journal:  World J Oncol       Date:  2019-12-16

9.  Muscle invasive bladder cancer in Upper Egypt: the shift in risk factors and tumor characteristics.

Authors:  Ali H Zarzour; Mohie Selim; Alaa A Abd-Elsayed; Diaa A Hameed; Mohammad A Abdelaziz
Journal:  BMC Cancer       Date:  2008-08-29       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.